Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
How Soy Found Its Way Into Everything
From milk to canned tuna to shampoo, soy is in a good majority of our day-to-day products. It’s added to around 60% of the nation’s processed foods. Soy has been known to provide some real health benefits, like high protein. But there are legitimate health and environmental consequences that raise the question: why do we use so much soy? And should we?
Why Obnoxiously Loud Car Alarms Aren't As Common Today
If you lived in a big city in the 90s, you're probably one of the unlucky people who was kept up at night on a regular basis by errant car alarms. But today, those in that same big city hear alarms far less often than you did. So where did car alarms go? How have they evolved, and did we ever need them to begin with?
The Real Reason Washington D.C. Doesn't Have Skyscrapers
The skyline of Washington D.C. is stunted. You've probably heard that D.C. can't build skyscrapers taller than the U.S. Capital Building or the Washington Monument. But those are both myths from a bygone era. Cheddar tells the real story.
Load More